Genzyme to Sell Genetics Unit to Labcorp for $925 million

14.09.2010 - U.S. biotech firm Genzyme said it agreed to sell its genetic-testing business to Labcorp of America Holdings for $925 million in cash. Genzyme, which recently rejected a takeover...